Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Transdermal Tulobuterol in Pediatric Asthma Patients on Long-Term Leukotriene Receptor Antagonist Therapy: Results of a Randomized, Open-Label, Multicenter Clinical Trial in Japanese Children Aged 4-12 Years.
Katsunuma T, Fujisawa T, Mizuho N, Akira A, Nomura I, Yamaoka A, Kondo H, Masuda K, Yamaguchi K, Terada A, Ikeda M, Nishioka K, Adachi Y, Kurihara K. Katsunuma T, et al. Allergol Int. 2013;62(1):37-43. doi: 10.2332/allergolint.12-OA-0437. Epub 2015 Feb 27. Allergol Int. 2013. PMID: 28942989 Free article.
Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
Katsunuma T, Fujisawa T, Nagao M, Akasawa A, Nomura I, Yamaoka A, Kondo H, Masuda K, Yamaguchi K, Terada A, Ikeda M, Nishioka K, Adachi Y, Kurihara K. Katsunuma T, et al. Allergol Int. 2013 Mar;62(1):37-43. doi: 10.2332/allergolint.12-OA-0437. Epub 2012 Sep 25. Allergol Int. 2013. PMID: 23000726 Free article. Clinical Trial.
Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
Odajima H, Ebisawa M, Nagakura T, Fujisawa T, Akasawa A, Ito K, Doi S, Yamaguchi K, Katsunuma T, Kurihara K, Kondo N, Sugai K, Nambu M, Hoshioka A, Yoshihara S, Sato N, Seko N, Nishima S. Odajima H, et al. Among authors: katsunuma t. Allergol Int. 2015 Oct;64(4):364-70. doi: 10.1016/j.alit.2015.05.006. Epub 2015 Jun 10. Allergol Int. 2015. PMID: 26433533 Free article. Clinical Trial.
Optimal step-down approach for pediatric asthma controlled by salmeterol/fluticasone: A randomized, controlled trial (OSCAR study).
Akashi K, Mezawa H, Tabata Y, Atsuta J, Tokuda R, Kawada Y, Kitamura T, Murasugi H, Ito H, Tabata M, Shirao K, Sato S, Nishimura H, Fujiwara M, Masuda K, Arakawa H, Adachi Y, Yoshihara S, Fujisawa T, Katsunuma T. Akashi K, et al. Among authors: katsunuma t. Allergol Int. 2016 Jul;65(3):306-11. doi: 10.1016/j.alit.2016.02.010. Epub 2016 May 4. Allergol Int. 2016. PMID: 27155753 Free article. Clinical Trial.
Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma.
Odajima H, Ebisawa M, Nagakura T, Fujisawa T, Akasawa A, Ito K, Doi S, Yamaguchi K, Katsunuma T, Kurihara K, Teramoto T, Sugai K, Nambu M, Hoshioka A, Yoshihara S, Sato N, Seko N, Nishima S. Odajima H, et al. Among authors: katsunuma t. Allergol Int. 2017 Jan;66(1):106-115. doi: 10.1016/j.alit.2016.06.004. Epub 2016 Aug 6. Allergol Int. 2017. PMID: 27507228 Free article. Clinical Trial.
Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial.
Nagao M, Ikeda M, Fukuda N, Habukawa C, Kitamura T, Katsunuma T, Fujisawa T; LePAT (Leukotriene and Pediatric Asthma Translational Research Network) investigators. Nagao M, et al. Among authors: katsunuma t. Allergol Int. 2018 Jan;67(1):72-78. doi: 10.1016/j.alit.2017.04.008. Epub 2017 May 16. Allergol Int. 2018. PMID: 28526210 Free article. Clinical Trial.
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial.
Fujisawa T, Shimoda T, Masuyama K, Okubo K, Honda K, Okano M, Katsunuma T, Urisu A, Kondo Y, Odajima H, Kurihara K, Nagata M, Taniguchi M, Taniuchi S, Doi S, Matsumoto T, Hashimoto S, Tanaka A, Natsui K, Abe N, Ozaki H. Fujisawa T, et al. Among authors: katsunuma t. Allergol Int. 2018 Jul;67(3):347-356. doi: 10.1016/j.alit.2017.11.004. Epub 2017 Dec 7. Allergol Int. 2018. PMID: 29233461 Free article. Clinical Trial.
Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
Katsunuma T, Ohya Y, Fujisawa T, Akashi K, Imamura N, Ebisawa M, Daikoku K, Kondo N, Terada A, Doi S, Nishimuta T, Noma T, Hamasaki Y, Kurihara K, Masuda K, Yamada T, Yamada M, Yoshihara S, Watanabe K, Watanabe T, Kitabayashi T, Morikawa A, Nishima S; Protective Effect of Tulobuterol Patch on the Long-term Management of Asthma in Young Children Study Group. Katsunuma T, et al. Allergy Asthma Proc. 2012 May-Jun;33(3):e28-34. Allergy Asthma Proc. 2012. PMID: 22737706 Clinical Trial.
Low-dose l-isoproterenol versus salbutamol in hospitalized pediatric patients with severe acute exacerbation of asthma: A double-blind, randomized controlled trial.
Katsunuma T, Fujisawa T, Maekawa T, Akashi K, Ohya Y, Adachi Y, Hashimoto K, Mizuno M, Imai T, Oba MS, Sako M, Ohashi Y, Nakamura H. Katsunuma T, et al. Allergol Int. 2019 Jul;68(3):335-341. doi: 10.1016/j.alit.2019.02.001. Epub 2019 Mar 5. Allergol Int. 2019. PMID: 30846304 Free article. Clinical Trial.
Executive summary: Japanese pediatric guideline for the treatment and management of asthma (JPGL) 2020.
Adachi Y, Takizawa T, Futamura M, Fujisawa T, Yoshihara S; Committee for Japanese Pediatric Guideline for the Treatment and Management of Asthma; Japanese Society of Pediatric Allergy and Clinical Immunology; Japanese Society of Allergology. Adachi Y, et al. Allergol Int. 2022 Oct;71(4):472-480. doi: 10.1016/j.alit.2022.07.007. Epub 2022 Sep 6. Allergol Int. 2022. PMID: 36085113 Free article. Review.
142 results